Clinical Trial Update: Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the combination of oxaliplatin, paclitaxel, and bevacizumab in advanced peritoneal carcinomatosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• Bevacizumab (bevacizumab)
• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peritoneal Cancer | Phase 1 | Status: COMPLETED